Atorvastatin Pre-Treatment Study In Asian Patients With Acute Coronary Syndrome

NCT ID: NCT00728988 Phase: PHASE4 Status: COMPLETED Enrollment: 499 Completion: 2010-04

Conditions

Acute Coronary Syndrome

Interventions

Atorvastatin, Atorvastatin

Summary

This present study is specifically designed to examine the efficacy and safety of a high pre-treatment dose of atorvastatin in Asian patients with NSTE-ACS in China and the Republic of Korea, by using a treatment paradigm similar to that employed in the ARMYDA-ACS study.

Primary Outcome

Percentage of Participants With Major Adverse Cardiac Events (MACE) (Incidence of MACE) at 30 Days Post-percutaneous Coronary Intervention (PCI)

Source

ClinicalTrials.gov